Research Article - (2015) Volume 6, Issue 4

Efficiency of Intensive Immune -Suppression Treatment with Rituximab in Acquired Thrombotic Thrombocytopenic Purpura: A Chinese Case study

Fang Hu1,2, Ziqiang Yu1,2*, Jian Su1,2, Ling Sun1,2, Tianqin Wu3, Zhaoyue Wang1,2, Xia Bai1,2 and Changgeng Ruan1,2
1Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, The First Affiliated Hospital of Soochow University, Suzhou, China
2Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
3Department of Hematology, 100th Hospital of PLA, Suzhou, 215007, China
*Corresponding Author: